Science Market Update

UC Davis Receives $11.5M in Funding for Fragile X Research

Posted by Rebecca Partridge on Tue, Jan 03, 2017

Currently, there are no FDA approved medications for treating fragile X syndrome. That may soon change, thanks to a $11.5 million NIH grant awarded to UC Davis Medical Center. The new funding will allow researchers to test a new drug that is designed to improve language learning for children with fragile X syndrome. UC Davis is one of only two medical centers approved for the drug trail in the nation. Since UC Davis Medical Center is home to the renowned MIND Institute, which hosts the Fragile X Research and Treatment Center, it is a logical choice for the treatment study.

Read More

Tags: CA, California, Research Funding, Drug Development, research grant, UC Davis - Medical Center, Southwest Region, new research grant, UCD, drug evaluation, BioResearch Product Faire, Bioresearch Grant

UC Davis MIND Institute Receives $6.5 Million and Elite IDDRC Status

Posted by Emily Olson on Mon, May 05, 2014

This prestigious designation makes the MIND Institute one of only fifteen Intellectual and Developmental Disabilities Research Centers in the country. Transition into this program is made possible by a five-year $6.5 million NIH grant and gives the institute critical new resources that will accelerate its progress in neurodevelopment research.

Read More

Tags: University of California Davis Medical Center, Bioinformatics, neurodevelopmental disorders, assays, molecular biology imaging, biological analysis, immunoassays, environmental contaminants, Autism, UCDMC, Funding, Research, NIH, UC Davis, UCD, grant, drug evaluation, developmental disabilities

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!